Skip to search formSkip to main contentSkip to account menu

Xeomin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
AIM To study the electromiographic (EMG) parameters and to evaluate the therapeutic efficacy of a combination of central… 
2019
2019
Background: Blepharospasm is a focal dystonia manifested by repetitive spasms of eyelid muscles which results in involuntary eye… 
2017
2017
AIM To assess the safety and clinical and neurophysiological efficacy of xeomin in children with spastic equinus and equinovarus… 
2016
2016
Study shows “accepted” equivalents of neurotoxin treatment dosages do not deliver comparable results. 
2013
2013
Aim: Incobotulinumtoxin A (xeomin) has been proposed as an alternative to abobotulinumtoxin A (dysport) and onabotulinumtoxin A… 
2012
2012
To reduce arm and hand spasticity, 28 patients in the early rehabilitation phase of ischemic hemisphere stroke received… 
2012
2012
To reduce arm and hand spasticity, 28 patients in the early rehabilitation phase of ischemic hemisphere stroke received… 
2010
2010
although no conclusive supporting evidence for that has been gathered to date, Dr. Cullis said. In a prospective, placebo… 
2009
2009
Background and purpose:  Botulinum toxin type A (BoNT/A) is a highly effective and well‐tolerated treatment for focal dystonias…